arrow
S

Sahil Sahni

National Cancer Institute
H指数:4
被引数:69

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: A machine learning model reveals expansive downregulation of ligand-receptor interactions that enhance lymphocyte infiltration in melanoma with developed resistance to immune checkpoint blockade

作者更正:机器学习模型揭示了在黑色素瘤对免疫检查点阻断产生耐药性时,配体-受体相互作用的大规模下调增强了淋巴细胞浸润

2026-11-170
OAAI
Osimertinib, platinum, and etoposide for patients with metastatic EGFR/TP53/RB1-mutant lung cancers at risk for histological transformation

奥希替尼、铂类和依托泊苷用于有组织学转化风险的EGFR/TP53/RB1突变转移性肺癌患者

2026-11-110
PRE
Cholesterol efflux protein; ABCA1; supports anticancer functions of myeloid immune cells

胆固醇外流蛋白;ABCA1;支持髓系免疫细胞的抗癌功能

2026-01-010
PRE
The molecular cartography of malignant and benign sebaceous tumours

恶性与良性皮脂腺肿瘤的分子地图绘制

2025-12-190
OA
Enhanced prediction of breast cancer patient response to chemotherapy by integrating deconvolved expression patterns of immune, stromal and tumor cells

通过整合免疫细胞、基质细胞和肿瘤细胞的去卷积表达模式,增强对乳腺癌患者化疗反应的预测

2025-10-300
PRE
Longitudinal liquid biopsy identifies an early predictive biomarker of immune checkpoint blockade response in head and neck squamous cell carcinoma

王, B.; Saddawi-Konefka, R.; Clubb, L.M.; 唐S.; 吴D.; Mukherjee, S.; Sahni, S.; Dhruba, S.R.; 杨X.; Patiyal, S.; 等. 纵向液体活检识别头颈鳞状细胞癌中免疫检查点阻断反应的早期预测生物标志物。Nat. Commun. 2025, 16, 8161. [Google Scholar] [CrossRef]

2025-09-010
OAAI